MIST
Milestone Pharmaceuticals Inc.
Key Financials
Operating Income
$-62140000
↓ 47.6%
Net Income
$-63058000
↓ 51.9%
Revenue
$238000
N/A
EPS (Diluted)
$-0.75
↓ 11.9%
Total Liabilities
$71.8M
↑ 15.1%
Shareholders' Equity
$41.8M
↑ 217.7%
Long-term Debt
$57.2M
↑ 7.2%
Total Assets
$113.6M
↑ 50.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 6/15/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| 4 | 6/12/2026 | View on SEC |
| EFFECT | 5/22/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | MIST |
| Company Name | Milestone Pharmaceuticals Inc. |
| CIK | 1408443 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | A8 |
| Phone | (514) 336-0444 |